194 related articles for article (PubMed ID: 33797903)
1. Design, Synthesis, and Structural Characterization of Lysine Covalent BH3 Peptides Targeting Mcl-1.
Gambini L; Udompholkul P; Baggio C; Muralidharan A; Kenjić N; Assar Z; Perry JJP; Pellecchia M
J Med Chem; 2021 Apr; 64(8):4903-4912. PubMed ID: 33797903
[TBL] [Abstract][Full Text] [Related]
2. Crystal Structures of Anti-apoptotic BFL-1 and Its Complex with a Covalent Stapled Peptide Inhibitor.
Harvey EP; Seo HS; Guerra RM; Bird GH; Dhe-Paganon S; Walensky LD
Structure; 2018 Jan; 26(1):153-160.e4. PubMed ID: 29276033
[TBL] [Abstract][Full Text] [Related]
3. Binding affinity of pro-apoptotic BH3 peptides for the anti-apoptotic Mcl-1 and A1 proteins: Molecular dynamics simulations of Mcl-1 and A1 in complex with six different BH3 peptides.
Modi V; Sankararamakrishnan R
J Mol Graph Model; 2017 May; 73():115-128. PubMed ID: 28279820
[TBL] [Abstract][Full Text] [Related]
4. Tertiary Structural Motif Sequence Statistics Enable Facile Prediction and Design of Peptides that Bind Anti-apoptotic Bfl-1 and Mcl-1.
Frappier V; Jenson JM; Zhou J; Grigoryan G; Keating AE
Structure; 2019 Apr; 27(4):606-617.e5. PubMed ID: 30773399
[TBL] [Abstract][Full Text] [Related]
5. Binding modes of Bcl-2 homology 3 (BH3) peptides with anti-apoptotic protein A1 and redesign of peptide inhibitors: a computational study.
Chen Y; Wang J; Zhang J; Wang W
J Biomol Struct Dyn; 2018 Nov; 36(15):3967-3977. PubMed ID: 29137527
[TBL] [Abstract][Full Text] [Related]
6. Novel Mcl-1/Bcl-2 dual inhibitors created by the structure-based hybridization of drug-divided building blocks and a fragment deconstructed from a known two-face BH3 mimetic.
Zhang Z; Su P; Li X; Song T; Chai G; Yu X; Zhang K
Arch Pharm (Weinheim); 2015 Feb; 348(2):89-99. PubMed ID: 25641608
[TBL] [Abstract][Full Text] [Related]
7. Relationship between helix stability and binding affinities: molecular dynamics simulations of Bfl-1/A1-binding pro-apoptotic BH3 peptide helices in explicit solvent.
Modi V; Lama D; Sankararamakrishnan R
J Biomol Struct Dyn; 2013; 31(1):65-77. PubMed ID: 22803956
[TBL] [Abstract][Full Text] [Related]
8. hBfl-1/hNOXA Interaction Studies Provide New Insights on the Role of Bfl-1 in Cancer Cell Resistance and for the Design of Novel Anticancer Agents.
Barile E; Marconi GD; De SK; Baggio C; Gambini L; Salem AF; Kashyap MK; Castro JE; Kipps TJ; Pellecchia M
ACS Chem Biol; 2017 Feb; 12(2):444-455. PubMed ID: 28026162
[TBL] [Abstract][Full Text] [Related]
9. Stapled BH3 peptides against MCL-1: mechanism and design using atomistic simulations.
Joseph TL; Lane DP; Verma CS
PLoS One; 2012; 7(8):e43985. PubMed ID: 22952838
[TBL] [Abstract][Full Text] [Related]
10. Designed BH3 peptides with high affinity and specificity for targeting Mcl-1 in cells.
Foight GW; Ryan JA; Gullá SV; Letai A; Keating AE
ACS Chem Biol; 2014 Sep; 9(9):1962-8. PubMed ID: 25052212
[TBL] [Abstract][Full Text] [Related]
11. Molecular dynamics study of segment peptides of Bax, Bim, and Mcl-1 BH3 domain of the apoptosis-regulating proteins bound to the anti-apoptotic Mcl-1 protein.
Zhao RN; Fan S; Han JG; Liu G
J Biomol Struct Dyn; 2015; 33(5):1067-81. PubMed ID: 24865469
[TBL] [Abstract][Full Text] [Related]
12. Mcl-1-Bim complexes accommodate surprising point mutations via minor structural changes.
Fire E; Gullá SV; Grant RA; Keating AE
Protein Sci; 2010 Mar; 19(3):507-19. PubMed ID: 20066663
[TBL] [Abstract][Full Text] [Related]
13. Peptide screening to knockdown Bcl-2's anti-apoptotic activity: implications in cancer treatment.
Raghav PK; Verma YK; Gangenahalli GU
Int J Biol Macromol; 2012 Apr; 50(3):796-814. PubMed ID: 22155216
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel Mcl-1 protein binding motif.
Placzek WJ; Sturlese M; Wu B; Cellitti JF; Wei J; Pellecchia M
J Biol Chem; 2011 Nov; 286(46):39829-35. PubMed ID: 21953453
[TBL] [Abstract][Full Text] [Related]
15. A comparison of two strategies for affinity maturation of a BH3 peptide toward pro-survival Bcl-2 proteins.
Zhang S; Long A; Link AJ
ACS Synth Biol; 2012 Mar; 1(3):89-98. PubMed ID: 23651073
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of diverse α/β-backbone patterns for functional α-helix mimicry: analogues of the Bim BH3 domain.
Boersma MD; Haase HS; Peterson-Kaufman KJ; Lee EF; Clarke OB; Colman PM; Smith BJ; Horne WS; Fairlie WD; Gellman SH
J Am Chem Soc; 2012 Jan; 134(1):315-23. PubMed ID: 22040025
[TBL] [Abstract][Full Text] [Related]
17. Conformational changes in Bcl-2 pro-survival proteins determine their capacity to bind ligands.
Lee EF; Czabotar PE; Yang H; Sleebs BE; Lessene G; Colman PM; Smith BJ; Fairlie WD
J Biol Chem; 2009 Oct; 284(44):30508-17. PubMed ID: 19726685
[TBL] [Abstract][Full Text] [Related]
18. The BH3 alpha-helical mimic BH3-M6 disrupts Bcl-X(L), Bcl-2, and MCL-1 protein-protein interactions with Bax, Bak, Bad, or Bim and induces apoptosis in a Bax- and Bim-dependent manner.
Kazi A; Sun J; Doi K; Sung SS; Takahashi Y; Yin H; Rodriguez JM; Becerril J; Berndt N; Hamilton AD; Wang HG; Sebti SM
J Biol Chem; 2011 Mar; 286(11):9382-92. PubMed ID: 21148306
[TBL] [Abstract][Full Text] [Related]
19. Anti-apoptotic Bcl-XL protein in complex with BH3 peptides of pro-apoptotic Bak, Bad, and Bim proteins: comparative molecular dynamics simulations.
Lama D; Sankararamakrishnan R
Proteins; 2008 Nov; 73(2):492-514. PubMed ID: 18452209
[TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics simulations of pro-apoptotic BH3 peptide helices in aqueous medium: relationship between helix stability and their binding affinities to the anti-apoptotic protein Bcl-X(L).
Lama D; Sankararamakrishnan R
J Comput Aided Mol Des; 2011 May; 25(5):413-26. PubMed ID: 21523491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]